Chronic Mountain Sickness (Cms) Misdiagnosed As High Altitude Cerebral Edema (Hace) At Extreme Altitude (6400 M/21000 Ft)

Document Type : Case Report


Clinical Microbiology, Army College of Medical Sciences and Base Hospital, Delhi Cantt 110010, India


Introduction: Chronic mountain sickness (CMS) represents a syndrome of secondary polycythemia along with thrombocytopenia, altered hemorheology, pulmonary and systemic hypertension, and congestive heart failure, occurring due to hypobaric hypoxia-anoxia-induced erythropoiesis reported in both native mountain residents and new climbers after prolonged stays at high and extreme altitudes.
Case Presentation: A healthy non-smoker non-drinker reported occipital headache, breathlessness, and insomnia after an uneventful stay of 70 days at 6400 m/21000 ft. His hemoglobin was 21 gm/dL. The patient was diagnosed as having a case of CMS with a Qinghai CMS score >6. Therapeutic phlebotomy was performed; 350 mL was drained on two occasions, reducing his hemoglobin to 14.6 gm/dL.
Conclusion: The altered presentation, difficult diagnosis, evacuation, and long-term management highlighted in this case occurring at 6400 m/21 000 ft in the Karakoram Himalayas represents the insidious nature of altitude sickness in acclimatized subjects.


  1. León-Velarde F, Villafuerte FC, Richalet JF. Chronic mountain sickness and the heart. Prog Cardiovasc Dis. 2010 ;52(6):540-549. doi:10.1016/j.pcad.2010.02.012.
  2. Khan ID. Extreme Altitude Pulmonary Oedema in Acclimatized Soldiers. Med J Armed Forces India. 2012;68(4):339-345. doi:10.1016/j.mjafi.2012.04.018.
  3. Khan ID. Comorbid cerebral and pulmonary edema at 7010 m/23000 ft: an extreme altitude perspective. J Med. 2013;14(2):153-155. doi:10.3329/jom.v14i2.19668.
  4. Khan ID. Cerebral venous sinus thrombosis (CVST) masquerading as high altitude cerebral edema (HACE) at extreme altitude (6700 m/22000 ft). Int J Travel Med Glob Health. 2016;4(3):96-98. doi:10.21859/ijtmgh-040306.
  5. Khan ID, Sahni AK. Possession syndrome at high altitude (4575 m/15000 ft). Kathmandu Univ Med J (KUMJ). 2013;43(3):247-249.
  6. Fujimaki T, Matsutani M, Asai A, Kohno T, Koike M. Cerebral venous thrombosis due to high altitude polycythemia. J Neurosurg. 1986;64:148-1450.
  7. Zubieta-Castillo G, Zubieta-Callaja G, Arano E, Zubieta-alleja L. Respiratory disease, chronic mountain sickness and gender differences at high altitude. In: Ohno H, Kobayashi T, Masuyama S, Nakashima M, eds. Press Committee of the 3rd World Congress on Mountain Medicine and High Altitude Physiology, Matsumoto, Japan; 1998:132-137.
  8. Kryger M, McCullough R, Doekel R, et al. Excessive polycythemia of high altitude: role of ventilatory drive and lung disease. Am Rev Respir Dis. 1978;118(4):659-66.
  9. Villafuerte FC. New genetic and physiological factors for excessive erythrocytosis and Chronic Mountain Sickness. J Appl Physiol (1985). 2015;119(12):1481-1486. doi:10.1152/japplphysiol.00271.2015.
  10. Jiang C, Chen J, Liu F, et al. Chronic mountain sickness in Chinese Han males who migrated to the Qinghai-Tibetan plateau: application and evaluation of diagnostic criteria for chronic mountain sickness. BMC Public Health. 2014;14:701. doi:10.1186/1471-2458-14-701.
  11. Xie SW, Liu C, Gao YX, et al. The study of prevalence rate, and clinical characteristics of high altitude deterioration.Eur Rev Med Pharmacol Sci. 2015;19(18):3444-3449.
  12. Lorenzo FR, Huff C, Myllymäki M, et al. A genetic mechanism for Tibetan high-altitude adaptation. Nat Genet. 2014;46(9):951-956. doi:10.1038/ng.3067.
  13. Sahota IS, Panwar NS. Prevalence of chronic mountain sickness in high altitude districts of Himachal Pradesh. Indian J Occup Environ Med. 2013;17(3):94-100. doi:10.4103/0019-5278.130839.
  14. Li X, Pei T, Xu H, et al. Ecological study of community-level factors associated with chronic mountain sickness in the young male chinese immigrant population in Tibet. J Epidemiol. 2012;22(2):136-143. doi:10.2188/jea.JE20110058.